Breast Cancer Foundation NZ
A hormone inhibitor that reduces risk of developing breast cancer
February 2014
Research Grant
What is the problem and who is affected?
In breast cancer patients, human growth hormone (GH) production in tumours is associated with an increased risk of metastasis as well as reduced survival. This means that if GH production can be blocked, as it is in humans and animals born with a GH-receptor deficiency, this risk could be dramatically reduced, if not eliminated.
What is this research hoping to achieve?
Professor Perry and her team will use a specialised assay to discover and develop molecules that can be used to inhibit the GH receptor and, therefore, block GH production. They will then test these inhibitors to determine whether they could be used as a therapeutic treatment for breast cancer patients.
-
AprilResearch Grant
Targeting immune response in ER+ breast cancer patients
-
FebruaryResearch Grant
Synthetic target of lobular breast cancer
-
FebruaryResearch Grant
A hormone inhibitor that reduces risk of developing breast cancer
-
FebruaryResearch Grant
The role of fatty tissue in the spread of breast cancer
-
FebruaryMedical Equipment
L-Dex Machines